MLSS

Milestone Scientific Inc

Add to Watchlist

Advanced Chart

0.590

-0.012(-1.993%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

0.6299

Open

0.603

VWAP

0.59

Vol

42.78K

Mkt Cap

46.36M

Low

0.5761

Amount

25.27K

EV/EBITDA(TTM)

Total Shares

77.23M

45.90M

EV/OCF(TTM)

P/S(TTM)

5.24

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

2.50M

+12.08%

-0.020

-33.33%

2.48M

+23.12%

-0.020

-0%

Estimates Revision

The market is revising No Change the revenue expectations for Milestone Scientific Inc. (MLSS) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -38.20%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-38.20%

In Past 3 Month

2 Analyst Rating

111.83% Upside

Wall Street analysts forecast MLSS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MLSS is 1.25 USD with a low forecast of 0.50 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

111.83% Upside

Current: 0.590

Low

0.50

Averages

1.25

High

2.00

111.83% Upside

Current: 0.590

Low

0.50

Averages

1.25

High

2.00

Benchmark

Bruce Jackson

Buy

Reiterates

$1.25

2024-11-20

Reason

Benchmark

Bruce Jackson

Price Target

$1.25

2024-11-20

Reiterates

Buy

Reason

Benchmark

Bruce Jackson

Buy

Initiates

$1.25

2024-10-10

Reason

Benchmark

Bruce Jackson

Price Target

$1.25

2024-10-10

Initiates

Buy

Reason

Benchmark initiated coverage of Milestone Scientific with a Speculative Buy rating and $1.25 price target.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Milestone Scientific Inc (MLSS.A) is -8.43, compared to its 5-year average forward P/E of -16.31. For a more detailed relative valuation and DCF analysis to assess Milestone Scientific Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-16.31

Current PE

-8.43

Overvalued PE

-9.17

Undervalued PE

-23.45

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

8.60

Current PS

4.51

Overvalued PS

13.47

Undervalued PS

3.73

Financials

Annual

Quarterly

FY2025Q2

YoY :

+25.34%

2.32M

Total Revenue

FY2025Q2

YoY :

-16.61%

-1.48M

Operating Profit

FY2025Q2

YoY :

-763.17%

-1.48M

Net Income after Tax

FY2025Q2

-0.02

EPS - Diluted

FY2025Q2

YoY :

-327.61%

-1.77M

Free Cash Flow

FY2025Q2

YoY :

-9.11%

68.78

Gross Profit Margin - %

FY2025Q2

YoY :

+77.99%

-57.99

FCF Margin - %

FY2025Q2

YoY :

-629.27%

-63.83

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

69.2K

USD

3-6

Months

228.9K

USD

6-9

Months

0.0

USD

0-12

Months

116.0K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

69.2K

USD

3-6

Months

228.9K

USD

6-9

Months

0.0

USD

0-12

Months

116.0K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

MLSS News & Events

Events Timeline

2025-08-06 (ET)

2025-08-06

08:34:44

Milestone Scientific appoints Jason Papes SVP, global head of sales, marketing

2025-08-01 (ET)

2025-08-01

08:33:49

Milestone Scientific appoints Hines as CEO

2025-07-17 (ET)

2025-07-17

08:34:46

Milestone Scientific starts sales of CompuFlu Epidural at The Painless Center

News

9.5

08-13Newsfilter

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

5.0

08-01Newsfilter

Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer

5.0

07-17Newsfilter

Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey

People Also Watch

ALXO

ALX Oncology Holdings Inc

Iron Horse Acquisitions Corp

Coda Octopus Group Inc

Horizon Space Acquisition I Corp

Oramed Pharmaceuticals Inc

Paranovus Entertainment Technology Ltd

0.716

USD

+3.77%

FAQ

What is Milestone Scientific Inc (MLSS) stock price today?

The current price of MLSS is 0.5901 USD — it has decreased -1.99 % in the last trading day.

MLSS

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

MLSS News & Events

Events Timeline

News

People Also Watch

FAQ

What is Milestone Scientific Inc (MLSS) stock price today?

What is Milestone Scientific Inc (MLSS)'s business?

What is the price predicton of MLSS Stock?

What is Milestone Scientific Inc (MLSS)'s revenue for the last quarter?

What is Milestone Scientific Inc (MLSS)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Milestone Scientific Inc (MLSS)'s fundamentals?

How many employees does Milestone Scientific Inc (MLSS). have?

What is Milestone Scientific Inc (MLSS) market cap?